Isabel Briz Hernández
Biographic Data
| ID | 237461 |
|---|---|
| NAME | Isabel Briz Hernández |
| GIVEN NAMES | Isabel Briz |
| FAMILY NAME | Hernández |
| SIGNATURE | HERNÁNDEZ I B |
| AFFILIATIONS | University College Dublin |
| ORCID | 0000-0001-8693-7213 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2025 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
“Beyond the State: First-Person Ethics and the Governance of Targeted Therapies in China”
The development of targeted therapies sits at the intersection of cutting-edge science, patient care, and complex social dynamics. Drawing on ethnographic fieldwork conducted in China between 2018 and 2020, this paper discusses how experimental targeted therapies are governed not only by formal regulations but also by the ethical judgments of non-state actors. Two vignettes illuminate this argument: first, the encounter between a prominent biotec…
Miscellaneous Care: Bridging the In-between of Translational Medicine
Based on fieldwork in China on oncology clinical trials for immunotherapy which involve foreign patients as trial subjects, in this paper, I illustrate how the source material needed for the trial (the patient’s T cells) is a scarce biological substance that needs to be generated and crafted though the efforts of patients, doctors, nurses, or lab technicians, as well as other staff: chauffeurs, translators, and foreign patient coordinators. Among…
The genomic promise of cancer as "not-yet-treatable" and the moral burden of "trying
Based on fieldwork conducted in China from November 2018 to January 2020 on biomedical innovation with advanced therapies open to foreigners, in this paper I address the question of why parents of children with incurable cancer decide to access experimental treatment on the other side of the world. While work on the "political economy of hope" has already extensively researched the relation between biomedical technology and hope, I delve into oth…
No prominent works on this page.
Miscellaneous Care: Bridging the In-between of Translational Medicine
Based on fieldwork in China on oncology clinical trials for immunotherapy which involve foreign patients as trial subjects, in this paper, I illustrate how the source material needed for the trial (the patient’s T cells) is a scarce biological substance that needs to be generated and crafted though the efforts of patients, doctors, nurses, or lab technicians, as well as other staff: chauffeurs, translators, and foreign patient coordinators. Among…
The genomic promise of cancer as "not-yet-treatable" and the moral burden of "trying
Based on fieldwork conducted in China from November 2018 to January 2020 on biomedical innovation with advanced therapies open to foreigners, in this paper I address the question of why parents of children with incurable cancer decide to access experimental treatment on the other side of the world. While work on the "political economy of hope" has already extensively researched the relation between biomedical technology and hope, I delve into oth…
“Beyond the State: First-Person Ethics and the Governance of Targeted Therapies in China”
The development of targeted therapies sits at the intersection of cutting-edge science, patient care, and complex social dynamics. Drawing on ethnographic fieldwork conducted in China between 2018 and 2020, this paper discusses how experimental targeted therapies are governed not only by formal regulations but also by the ethical judgments of non-state actors. Two vignettes illuminate this argument: first, the encounter between a prominent biotec…
Biomedical Ethics and Regulation (3 works) · Ethics in Clinical Research (2 works) · Medicine (2 works) · Biomedical and Engineering Education (1 works) · Biotechnology and Related Fields (1 works) · Bridging (networking (1 works) · CAR-T cell therapy research (1 works) · Clinical governance (1 works) · Computer Science (1 works) · Corporate governance (1 works)